Latest Breaking News On - மருத்துவ ஆராய்ச்சி அடித்தளம் - Page 8 : comparemela.com

 E-Mail BOSTON - Use of a cosmetic laser invented at Massachusetts General Hospital (MGH) may improve the effectiveness of certain anti-tumor therapies and extend their use to more diverse forms of cancer. The strategy was tested and validated in mice, as described in a study published in Immune checkpoint inhibitors are important medications that boost the immune system s response against various cancers, but only certain patients seem to benefit from the drugs. The cancer cells of these patients often have multiple mutations that can be recognized as foreign by the immune system, thereby inducing an inflammatory response. In an attempt to expand the benefits of immune checkpoint inhibitors for additional patients, a team led by David E. Fisher, MD, PhD, director of the Mass General Cancer Center s Melanoma Program and director of MGH s Cutaneous Biology Research Center, conducted experiments in mice with a poorly immunogenic melanoma that is not hindered by immune checkpoint i

United statesUnited kingdomDavide fisherCancer center melanoma programNational institutes of healthCancer research instituteNational science foundationSheldong adelson medical research foundationLymphoma societyGap grant of the university zurichCutaneous biology research centerCancer research united kingdomSwiss national science foundationEvergrande centerMassachusetts general hospitalScience translational